RxSight (RXST) CBO Eric Weinberg Sells 2,041 Shares

What Happened

• Eric Weinberg, Chief Business Development Officer at RxSight (RXST), had 5,370 restricted stock units (RSUs converted/vested into common shares on 2026-08-31) and subsequently sold 2,041 shares in an open-market transaction on 2026-09-02 for $6.96 each, netting $14,205.
• The Form 4 also reports disposition of 5,370 shares in connection with the derivative conversion at $0.00 (this reflects the RSU conversion/settlement and related withholding, not a cash-for-shares purchase).

Key Details

• Transaction dates/prices:
  • 2026-08-31: 5,370 RSUs converted/vested into 5,370 shares (reported as exercise/conversion of derivative, code M).
  • 2026-09-02: Open-market sale of 2,041 shares at $6.96 each, proceeds $14,205 (code S).
  • 2026-08-31: Report also shows 5,370 shares disposed at $0.00 related to the derivative conversion (code M).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes:
  • F1: Each RSU equals a contingent right to one share.
  • F3: Shares sold to cover tax withholding on RSU vesting — explicitly not a discretionary sale.
  • F5: The RSU award vests in six installments (one‑sixth on or after Aug 31, 2026 and future dates through Feb 28, 2029), subject to continued service.
  • F2 & F4 note other holdings (ESPP shares and trust holdings) included in total holdings in the full filing.
• Filing timeliness: Report filed 2026-09-02 for the 2026-08-31 report date — appears timely.

Context

• This filing primarily reflects RSU vesting and related tax-withholding activity, plus a small open-market sale. Tax-withholding dispositions associated with RSU vesting are routine and, per the footnote, not discretionary trades by the insider.
• For retail investors, purchases are generally a stronger signal than routine vesting sales; this transaction should be viewed as an employee compensation event rather than an explicit endorsement or negative signal about the company.